| 101 |
16899133 | "Nutritional and chemopreventive anti-cancer agents up-regulate expression of p27Kip1, a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells". | 2006 Aug 9 |
1 |
| 102 |
16951146 | AKT regulation of estrogen receptor beta transcriptional activity in breast cancer. | 2006 Sep 1 |
1 |
| 103 |
17010069 | Targeting downstream effectors of epidermal growth factor receptor/HER2 in breast cancer with either farnesyltransferase inhibitors or mTOR antagonists. | 2006 |
1 |
| 104 |
17085387 | Expression of active Akt protects against tamoxifen-induced apoptosis in MCF-7 Cells. | 2006 Nov |
2 |
| 105 |
15475931 | Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen. | 2005 Feb |
1 |
| 106 |
16088978 | AKT activation predicts outcome in breast cancer patients treated with tamoxifen. | 2005 Oct |
6 |
| 107 |
16172194 | Antiestrogen-resistant human breast cancer cells require activated protein kinase B/Akt for growth. | 2005 Sep |
1 |
| 108 |
14990993 | Tamoxifen and tamoxifen ethyl bromide induce apoptosis in acutely damaged mammary epithelial cells through modulation of AKT activity. | 2004 May 6 |
9 |
| 109 |
15151944 | NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. | 2004 Jun |
4 |
| 110 |
15318929 | New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists. | 2004 |
1 |
| 111 |
15377841 | Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells. | 2004 Sep |
3 |
| 112 |
15585641 | Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity. | 2004 Dec 1 |
6 |
| 113 |
12538508 | ErbB (HER) receptors can abrogate antiestrogen action in human breast cancer by multiple signaling mechanisms. | 2003 Jan |
2 |
| 114 |
12631397 | Akt kinases in breast cancer and the results of adjuvant therapy. | 2003 |
2 |
| 115 |
12853346 | Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. | 2003 Jul |
5 |
| 116 |
12970748 | Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. | 2003 Sep 11 |
1 |
| 117 |
12479367 | Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. | 2002 Jul |
4 |
| 118 |
11139588 | Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. | 2001 Mar 30 |
2 |